J Chest Surg.
2024 May;57(3):319-322. 10.5090/jcs.23.132.
Percutaneous OxyRVAD in a Patient with Severe Respiratory Failure and Right Heart Failure: A Case Report
- Affiliations
-
- 1Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
- KMID: 2555803
- DOI: http://doi.org/10.5090/jcs.23.132
Abstract
- Venovenous extracorporeal membrane oxygenation (VV ECMO) is often used in cases of severe respiratory failure, especially in patients considered for lung transplantation. However, because many lung diseases can ultimately result in right heart failure, the treatment of secondary right heart failure can present a challenge when the patient is already under VV ECMO support. In such cases, an oxygenated-right ventricular assist device (OxyRVAD) can be used. OxyRVAD is designed to maintain anterograde blood flow and prevent right ventricular distension. Moreover, the pulmonary arterial cannula can be inserted percutaneously. We report a case in which percutaneous OxyRVAD was successfully implemented to manage right heart failure in a patient with respiratory failure who was on VV ECMO.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Hypothyroidism With Acute Renal Failure and Heart Failure
- Extracorporeal Life Support with a Twin-pulse Life Support (T-PLS) System
- Arteriovenous Fistula After Percutaneous Pinning of Sternocalvicular Joint: 1 case report
- Respiratory Syncytial Virus Infection Complicated by Extrapulmonary Manifestations
- Successful emergency transcatheter aortic valve implantation
